#IDIBELLseminars – Seeing is Believing: Visualising the Heterogeneous Metabolism of Breast Cancer
Tumours undergo constant Darwinian evolution and clonal diversification, the net result of which tends to be increased…
International Open Access Week 2022 – Webinars
-
from 24 to 30 October
#IDIBELLfellows: Romina Miranda / Marta Valle
07/10/2020 15:00-16:00
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
09/10/2020 13:00-14:00
Microsoft Teams Meeting
Career Day 2020
21/10/2020 -
21-22 October 2020
This event is being held online
La recerca en temps de pandèmia
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
21/10/2020 19:00-
VII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22/10/2020 -
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
06/11/2020 13:00-14:00
PhD Day 2020
12/11/2020 -
12-13 November 2020
this event is being held online
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
20/11/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
24/11/2020 12:00-
Xerrades Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
28/11/2020 10:00-19:00
Online i en directe:
https://sinergia.l-h.cat/
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
04/12/2020 13:00-14:00
Microsoft Teams Meeting
#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
18/12/2020 13:00-14:00
Microsoft Teams Meeting
- 1
- 2
- 3
- …
- 28
- Entrades següents »
Pint of Science 2024: Cómo luchar contra las arrugas del pulmón?
Envejecemos a partir de los 40-50 años (algunos incluso antes). Cuando nos miramos en el espejo percibimos…
#IDIBELLfellows: Iswarya Sreeram / Ana Cantos Cortes
From Senescence to cell death: exploring novel therapeutic approaches in Malignant Pleural Mesothelioma (MPM) Iswarya Sreeram –…
#IDIBELLseminars: Paper mills and predatory journals: emerging forms of scientific misconduct
Research misconduct is an understudied topic. Behind the classic publish or perish axiom, there are multiple and…
ONCOBELL 3rd International Symposium
New frontiers in cancer therapies and personalized medicine Barcelona, October 3rd – 4th, 2024 Venue: Auditorium HUB…
Dia internacional de les infermeres
13 de maig a les 15.30 h | Sala d’Actes de l’Hospital Universitari de Bellvitge Jornada acreditada…
IX EMDebate
Us presentem el programa de l’edició EMDebate d’enguany. Hem convidat a alguns dels principals especialistes en esclerosi…
Programa de actualización en esclerosis múltiple
Des de la Unitat d’Esclerosi Múltiple EMxarxa us presentem el programa de sessions “Actualización en Esclerosis Múltiple”,…
#IDIBELLseminars: Targeting lineage plasticity in prostate cancer
Drug resistance in cancer is often linked to changes in tumor cell state or lineage, but the…
#IDIBELLfellows: Laia Solé
Exploring the role of CDK8 in Young and Aged Hematopoietic Stem Cells: Expression, Kinase Activity, and Epigenetic…